AKTX
Price
$0.97
Change
-$0.08 (-7.62%)
Updated
Feb 21 closing price
Capitalization
25.68M
GLTO
Price
$4.51
Change
-$0.33 (-6.82%)
Updated
Feb 21 closing price
Capitalization
5.94M
Ad is loading...

AKTX vs GLTO

Header iconAKTX vs GLTO Comparison
Open Charts AKTX vs GLTOBanner chart's image
Akari Therapeutics
Price$0.97
Change-$0.08 (-7.62%)
Volume$29.97K
Capitalization25.68M
Galecto
Price$4.51
Change-$0.33 (-6.82%)
Volume$11.06K
Capitalization5.94M
AKTX vs GLTO Comparison Chart
Loading...
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKTX vs. GLTO commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTX is a Hold and GLTO is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (AKTX: $1.01 vs. GLTO: $4.82)
Brand notoriety: AKTX and GLTO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKTX: 150% vs. GLTO: 89%
Market capitalization -- AKTX: $25.68M vs. GLTO: $5.94M
AKTX [@Biotechnology] is valued at $25.68M. GLTO’s [@Biotechnology] market capitalization is $5.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTX’s FA Score shows that 1 FA rating(s) are green whileGLTO’s FA Score has 1 green FA rating(s).

  • AKTX’s FA Score: 1 green, 4 red.
  • GLTO’s FA Score: 1 green, 4 red.
According to our system of comparison, both AKTX and GLTO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKTX’s TA Score shows that 2 TA indicator(s) are bullish while GLTO’s TA Score has 2 bullish TA indicator(s).

  • AKTX’s TA Score: 2 bullish, 6 bearish.
  • GLTO’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, GLTO is a better buy in the short-term than AKTX.

Price Growth

AKTX (@Biotechnology) experienced а -8.49% price change this week, while GLTO (@Biotechnology) price change was +5.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

AKTX is expected to report earnings on Dec 01, 2023.

GLTO is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKTX($25.7M) has a higher market cap than GLTO($5.94M). GLTO YTD gains are higher at: 3.551 vs. AKTX (-17.492). GLTO has higher annual earnings (EBITDA): -19.68M vs. AKTX (-26.82M). GLTO has more cash in the bank: 19.7M vs. AKTX (2.25M). GLTO has less debt than AKTX: GLTO (32K) vs AKTX (1M). AKTX (0) and GLTO (0) have equivalent revenues.
AKTXGLTOAKTX / GLTO
Capitalization25.7M5.94M433%
EBITDA-26.82M-19.68M136%
Gain YTD-17.4923.551-493%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.25M19.7M11%
Total Debt1M32K3,125%
FUNDAMENTALS RATINGS
AKTX: Fundamental Ratings
AKTX
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKTXGLTO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
84%
Momentum
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
89%
Bullish Trend 6 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
79%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
87%
View a ticker or compare two or three
Ad is loading...
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

AKTX and

Correlation & Price change

A.I.dvisor tells us that AKTX and KPRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTX and KPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTX
1D Price
Change %
AKTX100%
-6.80%
KPRX - AKTX
30%
Poorly correlated
+2.76%
DSGN - AKTX
23%
Poorly correlated
+1.23%
ALLR - AKTX
23%
Poorly correlated
+2.22%
GLTO - AKTX
22%
Poorly correlated
+0.71%
ZVRA - AKTX
22%
Poorly correlated
-1.49%
More

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been closely correlated with DSGN. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLTO jumps, then DSGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+0.71%
DSGN - GLTO
83%
Closely correlated
+1.23%
TCRT - GLTO
56%
Loosely correlated
+0.62%
IMVT - GLTO
29%
Poorly correlated
+2.41%
VYNE - GLTO
28%
Poorly correlated
+1.21%
CRIS - GLTO
28%
Poorly correlated
-1.86%
More